Literature DB >> 35182904

A systems genetics approach delineates the role of Bcl2 in leukemia pathogenesis.

Xinfeng Wang1, Akhilesh Kumar Bajpai2, Qingqing Gu3, Arthur Centeno2, Athena Starlard-Davenport2, Pjotr Prins2, Fuyi Xu4, Lu Lu5.   

Abstract

Leukemia is a group of malignancies of the blood forming tissues, and is characterized by the uncontrolled proliferation of blood cells. In the United States, it accounts for approximately 3.5% and 4% of all cancer-related incidences and mortalities, respectively. The current study aimed to explore the role of Bcl2 and associated genes in leukemia pathogenesis using a systems genetics approach. The transcriptome data from BXD Recombinant Inbred (RI) mice was analyzed to identify the expression of Bcl2 in myeloid cells. eQTL mapping was performed to select the potential chromosomal region and subsequently identify the candidate gene modulating the expression of Bcl2. Furthermore, gene enrichment and protein-protein interaction (PPI) analyses of the Bcl2-coexpressed genes were performed to demonstrate the role of Bcl2 in leukemia pathogenesis. The Bcl2-coexpressed genes were found to be enriched in various hematopoietic system related functions, and multiple pathways related to signaling, immune response, and cancer. The PPI network analysis demonstrated direct interaction of hematopoietic function related genes, such as Bag3, Bak1, Bcl2l11, Bmf, Mapk9, Myc, Ppp2r5c, and Ppp3ca with Bcl2. The eQTL mapping identified a 4.5 Mb genomic region on chromosome 11, potentially regulating the expression of Bcl2. A multi-criteria filtering process identified Top2a, among the genes located in the mapped locus, as the best candidate upstream regulator for Bcl2 expression variation. Hence, the current study provides better insights into the role of Bcl2 in leukemia pathogenesis and demonstrates the significance of our approach in gaining new knowledge on leukemia. Furthermore, our findings from the PPI network analysis and eQTL mapping provide supporting evidence of leukemia-associated genes, which can be further explored for their functional importance in leukemia. DATA AVAILABILITY: The myeloid cell transcriptomic data of the BXD mice used in this study can be accessed through our GeneNetwork (http://www.genenetwork.org) with the accession number of GN144.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BXD mice; Co-expression; Myeloid cell; Transcriptome

Mesh:

Substances:

Year:  2022        PMID: 35182904      PMCID: PMC9272521          DOI: 10.1016/j.leukres.2022.106804

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.715


  61 in total

1.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

2.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

3.  miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the BCL2L11 and BAX Proapoptotic Genes.

Authors:  Tianxiang Hu; Yating Chong; Sumin Lu; Rebecca Wang; Haiyan Qin; Jeane Silva; Eiko Kitamura; Chang-Sheng Chang; LesleyAnn Hawthorn; John K Cowell
Journal:  Cancer Res       Date:  2018-05-07       Impact factor: 12.701

4.  Apoptosis induced by a new member of saponin family is mediated through caspase-8-dependent cleavage of Bcl-2.

Authors:  Jianbei Zhu; Lei Xiong; Biao Yu; Jiarui Wu
Journal:  Mol Pharmacol       Date:  2005-09-23       Impact factor: 4.436

5.  Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.

Authors:  Yuki Kagoya; Akihide Yoshimi; Keisuke Kataoka; Masahiro Nakagawa; Keiki Kumano; Shunya Arai; Hiroshi Kobayashi; Taku Saito; Yoichiro Iwakura; Mineo Kurokawa
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

6.  Bcl-2 overexpression enhances tumor-specific T-cell survival.

Authors:  Jehad Charo; Steven E Finkelstein; Navrose Grewal; Nicholas P Restifo; Paul F Robbins; Steven A Rosenberg
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

7.  bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells.

Authors:  D Delia; A Aiello; D Soligo; E Fontanella; C Melani; F Pezzella; M A Pierotti; G Della Porta
Journal:  Blood       Date:  1992-03-01       Impact factor: 22.113

8.  Q482H mutation of procaspase-8 in acute myeloid leukemia abolishes caspase-8-mediated apoptosis by impairing procaspase-8 dimerization.

Authors:  Ming Li; Jianfeng Yao; Xiangxi Zhang; Xuan Chen; Juan Chen; Yingying Guan; Xiaoyu Yang
Journal:  Biochem Biophys Res Commun       Date:  2017-12-02       Impact factor: 3.575

9.  BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.

Authors:  Jing-Dong Zhou; Ting-Juan Zhang; Zi-Jun Xu; Yu Gu; Ji-Chun Ma; Xi-Xi Li; Hong Guo; Xiang-Mei Wen; Wei Zhang; Lei Yang; Xing-Hui Liu; Jiang Lin; Jun Qian
Journal:  Diagn Pathol       Date:  2019-06-29       Impact factor: 2.644

Review 10.  TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?

Authors:  Matteo Molica; Carla Mazzone; Pasquale Niscola; Paolo de Fabritiis
Journal:  Front Oncol       Date:  2021-02-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.